Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Oct;64(4):631–644. doi: 10.1038/bjc.1991.375

Tumour progression and the nature of cancer.

W H Clark 1
PMCID: PMC1977704  PMID: 1911211

Abstract

The nature of neoplasia and its sometime end result, cancer, has been studied by exposition and explanation of the sequential lesions of tumour progression. Neoplastic lesions were divided into four classes on the basis of growth characteristics and whether lesional growth is confined to one or more tissue compartments. Class IA, the initial lesion, an orderly, probably clonal growth, usually differentiates and disappears. Class IB: Failure to differentiate accompanied by disorderly growth. Class IC: Randomly dispersed atypical cells, constituting a precursor state. Class II, intermediate lesions, apparently arising from the atypical cells, show temporally unrestricted growth within the tissue compartment of origin. Class III lesions, primary invasive cancers, show temporally unrestricted growth in two or more tissue compartments and metastasise along different paths, a property associated with extracellular matrix interaction. The metastatic pathways may result from different subsets of cells in the primary cancer. Class IV lesions are the metastases. It was concluded that, all neoplasms develop in the same way, have the same general behavioural characteristics, and, when malignant, all interact with the extracellular matrix of the primary and the secondary sites. The origins and development of cancer are considered to be pluralistic and not due to a discrete change in a cell, whose progeny, as a result of that discrete change, carries all of the information required to explain the almost limitless events of a neoplastic system.

Full text

PDF
631

Images in this article

642Figure 4
on p.642

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronson P. J., Ito K., Fukaya T., Hashimoto K., Mehregan A. H. Monoclonal antibody (AFH1) immunoreactive on morphologically abnormal basal melanocytes within dysplastic nevi, nevocellular nevus nests, and melanoma. J Invest Dermatol. 1988 Apr;90(4):452–458. doi: 10.1111/1523-1747.ep12460896. [DOI] [PubMed] [Google Scholar]
  2. Aso M., Hashimoto K., Eto H., Fukaya T., Ishihara M., Shimao S., Shimizu Y. Expression of Schwann cell characteristics in pigmented nevus. Immunohistochemical study using monoclonal antibody to Schwann cell associated antigen. Cancer. 1988 Sep 1;62(5):938–943. doi: 10.1002/1097-0142(19880901)62:5<938::aid-cncr2820620515>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  3. Bergman W., Ruiter D. J., Scheffer E., van Vloten W. A. Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis. Cancer. 1988 Apr 15;61(8):1660–1666. doi: 10.1002/1097-0142(19880415)61:8<1660::aid-cncr2820610825>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  4. Bissell M. J., Hall H. G., Parry G. How does the extracellular matrix direct gene expression? J Theor Biol. 1982 Nov 7;99(1):31–68. doi: 10.1016/0022-5193(82)90388-5. [DOI] [PubMed] [Google Scholar]
  5. Clark W. H., Jr, Elder D. E., Guerry D., 4th, Braitman L. E., Trock B. J., Schultz D., Synnestvedt M., Halpern A. C. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989 Dec 20;81(24):1893–1904. doi: 10.1093/jnci/81.24.1893. [DOI] [PubMed] [Google Scholar]
  6. Clark W. H., Jr, Elder D. E., Guerry D., 4th, Epstein M. N., Greene M. H., Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol. 1984 Dec;15(12):1147–1165. doi: 10.1016/s0046-8177(84)80310-x. [DOI] [PubMed] [Google Scholar]
  7. Clark W. H., Jr Human cutaneous malignant melanoma as a model for cancer. Cancer Metastasis Rev. 1991 Jun;10(2):83–88. doi: 10.1007/BF00049406. [DOI] [PubMed] [Google Scholar]
  8. Dupont W. D., Page D. L. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985 Jan 17;312(3):146–151. doi: 10.1056/NEJM198501173120303. [DOI] [PubMed] [Google Scholar]
  9. Edelman G. M. Topobiology. Sci Am. 1989 May;260(5):76-82, 84-6, 88. doi: 10.1038/scientificamerican0589-76. [DOI] [PubMed] [Google Scholar]
  10. Elder D. E., Rodeck U., Thurin J., Cardillo F., Clark W. H., Stewart R., Herlyn M. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Cancer Res. 1989 Sep 15;49(18):5091–5096. [PubMed] [Google Scholar]
  11. Farber E. Clonal adaptation during carcinogenesis. Biochem Pharmacol. 1990 Jun 15;39(12):1837–1846. doi: 10.1016/0006-2952(90)90599-g. [DOI] [PubMed] [Google Scholar]
  12. Farber E., Sarma D. S. Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest. 1987 Jan;56(1):4–22. [PubMed] [Google Scholar]
  13. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  14. Feinberg S. M., Jagelman D. G., Sarre R. G., McGannon E., Fazio V. W., Lavery I. C., Weakley F. L., Easley K. A. Spontaneous resolution of rectal polyps in patients with familial polyposis following abdominal colectomy and ileorectal anastomosis. Dis Colon Rectum. 1988 Mar;31(3):169–175. doi: 10.1007/BF02552541. [DOI] [PubMed] [Google Scholar]
  15. Greene M. H., Clark W. H., Jr, Tucker M. A., Kraemer K. H., Elder D. E., Fraser M. C. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med. 1985 Apr;102(4):458–465. doi: 10.7326/0003-4819-102-4-458. [DOI] [PubMed] [Google Scholar]
  16. Herlyn M., Clark W. H., Rodeck U., Mancianti M. L., Jambrosic J., Koprowski H. Biology of tumor progression in human melanocytes. Lab Invest. 1987 May;56(5):461–474. [PubMed] [Google Scholar]
  17. Holzmann B., Bröcker E. B., Lehmann J. M., Ruiter D. J., Sorg C., Riethmüller G., Johnson J. P. Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes. Int J Cancer. 1987 Apr 15;39(4):466–471. doi: 10.1002/ijc.2910390410. [DOI] [PubMed] [Google Scholar]
  18. Howat A. J., Variend S. Lymphatic invasion in Spitz nevi. Am J Surg Pathol. 1985 Feb;9(2):125–128. doi: 10.1097/00000478-198502000-00007. [DOI] [PubMed] [Google Scholar]
  19. Kerbel R. S., Waghorne C., Korczak B., Lagarde A., Breitman M. L. Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications. Cancer Surv. 1988;7(4):597–629. [PubMed] [Google Scholar]
  20. Liotta L. A., Guirguis R., Stracke M. Biology of melanoma invasion and metastasis. Pigment Cell Res. 1987;1(1):5–15. doi: 10.1111/j.1600-0749.1987.tb00528.x. [DOI] [PubMed] [Google Scholar]
  21. Masri G. D., Clark W. H., Jr, Guerry D., 4th, Halpern A., Thompson C. J., Elder D. E. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol. 1990 Jun;22(6 Pt 1):1042–1048. doi: 10.1016/0190-9622(90)70149-c. [DOI] [PubMed] [Google Scholar]
  22. Morikawa K., Walker S. M., Nakajima M., Pathak S., Jessup J. M., Fidler I. J. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res. 1988 Dec 1;48(23):6863–6871. [PubMed] [Google Scholar]
  23. Newton J. A., Camplejohn R. S., McGibbon D. H. The flow cytometry of melanocytic skin lesions. Br J Cancer. 1988 Nov;58(5):606–609. doi: 10.1038/bjc.1988.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nicolson G. L. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res. 1987 Mar 15;47(6):1473–1487. [PubMed] [Google Scholar]
  25. Nowell P. C. Chromosomal and molecular clues to tumor progression. Semin Oncol. 1989 Apr;16(2):116–127. [PubMed] [Google Scholar]
  26. Page D. L., Dupont W. D. Anatomic markers of human premalignancy and risk of breast cancer. Cancer. 1990 Sep 15;66(6 Suppl):1326–1335. doi: 10.1002/1097-0142(19900915)66:14+<1326::aid-cncr2820661405>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  27. Parmiter A. H., Balaban G., Clark W. H., Jr, Nowell P. C. Possible involvement of the chromosome region 10q24----q26 in early stages of melanocytic neoplasia. Cancer Genet Cytogenet. 1988 Feb;30(2):313–317. doi: 10.1016/0165-4608(88)90200-2. [DOI] [PubMed] [Google Scholar]
  28. Prehn R. T. Lymphoid dependency and cutaneous melanoma. J Natl Cancer Inst. 1990 Apr 4;82(7):626–627. doi: 10.1093/jnci/82.7.626. [DOI] [PubMed] [Google Scholar]
  29. Rhodes A. R., Seki Y., Fitzpatrick T. B., Stern R. S. Melanosomal alterations in dysplastic melanocytic nevi. A quantitative, ultrastructural investigation. Cancer. 1988 Jan 15;61(2):358–369. doi: 10.1002/1097-0142(19880115)61:2<358::aid-cncr2820610227>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  30. Rubin H. Cancer as a dynamic developmental disorder. Cancer Res. 1985 Jul;45(7):2935–2942. [PubMed] [Google Scholar]
  31. Schmoeckel C., Stolz W., Sakai L. Y., Burgeson R. E., Timpl R., Krieg T. Structure of basement membranes in malignant melanoma and nevocytic nevi. J Invest Dermatol. 1989 May;92(5):663–668. doi: 10.1111/1523-1747.ep12696845. [DOI] [PubMed] [Google Scholar]
  32. Smith K. J., Barrett T. L., Skelton H. G., 3rd, Lupton G. P., Graham J. H. Spindle cell and epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol. 1989 Nov;13(11):931–939. doi: 10.1097/00000478-198911000-00003. [DOI] [PubMed] [Google Scholar]
  33. Stanbridge E. J., Der C. J., Doersen C. J., Nishimi R. Y., Peehl D. M., Weissman B. E., Wilkinson J. E. Human cell hybrids: analysis of transformation and tumorigenicity. Science. 1982 Jan 15;215(4530):252–259. doi: 10.1126/science.7053574. [DOI] [PubMed] [Google Scholar]
  34. Williams G. M. The pathogenesis of rat liver cancer caused by chemical carcinogens. Biochim Biophys Acta. 1980 May 6;605(2):167–189. doi: 10.1016/0304-419x(80)90003-7. [DOI] [PubMed] [Google Scholar]
  35. Yaar M., Woodley D. T., Gilchrest B. A. Human nevocellular nevus cells are surrounded by basement membrane components. Immunohistologic studies of human nevus cells and melanocytes in vivo and in vitro. Lab Invest. 1988 Feb;58(2):157–162. [PubMed] [Google Scholar]
  36. Yuspa S. H., Kilkenny A., Roop D. R. Aberrant differentiation in mouse skin carcinogenesis. IARC Sci Publ. 1988;(92):3–10. [PubMed] [Google Scholar]
  37. Zetter B. R. The cellular basis of site-specific tumor metastasis. N Engl J Med. 1990 Mar 1;322(9):605–612. doi: 10.1056/NEJM199003013220907. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES